• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻病毒诱导的白细胞介素-25在哮喘加重期驱动2型免疫反应和过敏性肺部炎症。

Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation.

作者信息

Beale Janine, Jayaraman Annabelle, Jackson David J, Macintyre Jonathan D R, Edwards Michael R, Walton Ross P, Zhu Jie, Man Ching Yee, Shamji Betty, Edwards Matt, Westwick John, Cousins David J, Yi Hwang You, McKenzie Andrew, Johnston Sebastian L, Bartlett Nathan W

机构信息

Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, UK.

MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK.

出版信息

Sci Transl Med. 2014 Oct 1;6(256):256ra134. doi: 10.1126/scitranslmed.3009124.

DOI:10.1126/scitranslmed.3009124
PMID:25273095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4246061/
Abstract

Rhinoviruses (RVs), which are the most common cause of virally induced asthma exacerbations, account for much of the burden of asthma in terms of morbidity, mortality, and associated cost. Interleukin-25 (IL-25) activates type 2-driven inflammation and is therefore potentially important in virally induced asthma exacerbations. To investigate this, we examined whether RV-induced IL-25 could contribute to asthma exacerbations. RV-infected cultured asthmatic bronchial epithelial cells exhibited a heightened intrinsic capacity for IL-25 expression, which correlated with donor atopic status. In vivo human IL-25 expression was greater in asthmatics at baseline and during experimental RV infection. In addition, in mice, RV infection induced IL-25 expression and augmented allergen-induced IL-25. Blockade of the IL-25 receptor reduced many RV-induced exacerbation-specific responses including type 2 cytokine expression, mucus production, and recruitment of eosinophils, neutrophils, basophils, and T and non-T type 2 cells. Therefore, asthmatic epithelial cells have an increased intrinsic capacity for expression of a pro-type 2 cytokine in response to a viral infection, and IL-25 is a key mediator of RV-induced exacerbations of pulmonary inflammation.

摘要

鼻病毒(RVs)是病毒诱发哮喘加重的最常见原因,在发病率、死亡率及相关费用方面,它是哮喘负担的重要组成部分。白细胞介素-25(IL-25)可激活2型驱动的炎症反应,因此在病毒诱发的哮喘加重中可能具有重要作用。为对此进行研究,我们检测了RV诱导的IL-25是否会导致哮喘加重。感染RV的培养哮喘支气管上皮细胞表现出更高的IL-25表达内在能力,这与供体的特应性状态相关。在体内,哮喘患者在基线期和实验性RV感染期间的人IL-25表达更高。此外,在小鼠中,RV感染诱导IL-25表达并增强变应原诱导的IL-25。阻断IL-25受体可减少许多RV诱导的加重特异性反应,包括2型细胞因子表达、黏液分泌以及嗜酸性粒细胞、中性粒细胞、嗜碱性粒细胞、T细胞和非T 2型细胞的募集。因此,哮喘上皮细胞在病毒感染时表达促2型细胞因子的内在能力增强,且IL-25是RV诱导的肺部炎症加重的关键介质。

相似文献

1
Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation.鼻病毒诱导的白细胞介素-25在哮喘加重期驱动2型免疫反应和过敏性肺部炎症。
Sci Transl Med. 2014 Oct 1;6(256):256ra134. doi: 10.1126/scitranslmed.3009124.
2
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.鼻病毒诱导的体内哮喘加重过程中依赖白细胞介素-33的2型炎症反应
Am J Respir Crit Care Med. 2014 Dec 15;190(12):1373-82. doi: 10.1164/rccm.201406-1039OC.
3
IL-25: the missing link between allergy, viral infection, and asthma?IL-25:过敏、病毒感染和哮喘之间缺失的一环?
Sci Transl Med. 2014 Oct 1;6(256):256fs38. doi: 10.1126/scitranslmed.3010273.
4
Dual role of the miR-146 family in rhinovirus-induced airway inflammation and allergic asthma exacerbation.miR-146 家族在鼻病毒诱导的气道炎症和过敏性哮喘恶化中的双重作用。
Clin Transl Med. 2021 Jun;11(6):e427. doi: 10.1002/ctm2.427.
5
Allergic environment enhances airway epithelial pro-inflammatory responses to rhinovirus infection.变应性环境增强气道上皮对鼻病毒感染的促炎反应。
Clin Sci (Lond). 2017 Mar 1;131(6):499-509. doi: 10.1042/CS20160939. Epub 2017 Jan 23.
6
Rhinovirus-Induced Cytokine Alterations With Potential Implications in Asthma Exacerbations: A Systematic Review and Meta-Analysis.鼻病毒诱导的细胞因子改变及其在哮喘恶化中的潜在意义:系统评价和荟萃分析。
Front Immunol. 2022 Feb 15;13:782936. doi: 10.3389/fimmu.2022.782936. eCollection 2022.
7
IL-1 receptor antagonist attenuates proinflammatory responses to rhinovirus in airway epithelium.白细胞介素-1 受体拮抗剂可减轻呼吸道上皮细胞对鼻病毒的促炎反应。
J Allergy Clin Immunol. 2023 Jun;151(6):1577-1584.e4. doi: 10.1016/j.jaci.2023.01.015. Epub 2023 Jan 26.
8
IFN-γ Blocks Development of an Asthma Phenotype in Rhinovirus-Infected Baby Mice by Inhibiting Type 2 Innate Lymphoid Cells.干扰素-γ通过抑制2型固有淋巴细胞来阻断鼻病毒感染的幼鼠哮喘表型的发展。
Am J Respir Cell Mol Biol. 2017 Feb;56(2):242-251. doi: 10.1165/rcmb.2016-0056OC.
9
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production.鼻病毒引起的下呼吸道疾病在哮喘中有所增加,且与病毒载量、Th1/2细胞因子及白细胞介素-10的产生有关。
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13562-7. doi: 10.1073/pnas.0804181105. Epub 2008 Sep 3.
10
γδT cells suppress inflammation and disease during rhinovirus-induced asthma exacerbations.γδT 细胞在鼻病毒诱导的哮喘加重期间抑制炎症和疾病。
Mucosal Immunol. 2013 Nov;6(6):1091-100. doi: 10.1038/mi.2013.3. Epub 2013 Feb 6.

引用本文的文献

1
Drugs Used in the Treatment of Viral Infections for the Prevention of Airway Remodeling in Asthma.用于治疗病毒感染以预防哮喘气道重塑的药物。
Mediators Inflamm. 2025 Jul 24;2025:5526526. doi: 10.1155/mi/5526526. eCollection 2025.
2
Single cell profiling of human airway identifies tuft-ionocyte progenitor cells displaying cytokine-dependent differentiation bias in vitro.对人类气道的单细胞分析鉴定出在体外表现出细胞因子依赖性分化偏向的簇状离子细胞祖细胞。
Nat Commun. 2025 Jun 4;16(1):5180. doi: 10.1038/s41467-025-60441-w.
3
Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled Asthma.特泽佩umab实现临床和生物学缓解:重度难治性哮喘的真实世界反应
Allergy. 2025 Jun;80(6):1669-1676. doi: 10.1111/all.16590. Epub 2025 May 14.
4
models to study viral-induced asthma exacerbation: a short review for a key issue.用于研究病毒诱导的哮喘加重的模型:一个关键问题的简短综述
Front Allergy. 2025 Mar 28;6:1530122. doi: 10.3389/falgy.2025.1530122. eCollection 2025.
5
Type 2 immunity in allergic diseases.过敏性疾病中的2型免疫。
Cell Mol Immunol. 2025 Mar;22(3):211-242. doi: 10.1038/s41423-025-01261-2. Epub 2025 Feb 17.
6
Impact of a Concurrent Respiratory Virus Infection on the Clinical Presentation and Response to Initial Treatment of Kawasaki Disease: A Single-Center Observational Study.同时感染呼吸道病毒对川崎病临床表现及初始治疗反应的影响:一项单中心观察性研究
J Clin Med. 2025 Jan 24;14(3):775. doi: 10.3390/jcm14030775.
7
Evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of SM17 in healthy volunteers: results from pre-clinical models and a first-in-human, randomized, double blinded clinical trial.SM17在健康志愿者中的安全性、耐受性、药代动力学和药效学评估:临床前模型及首次人体随机双盲临床试验结果
Front Immunol. 2024 Dec 9;15:1495540. doi: 10.3389/fimmu.2024.1495540. eCollection 2024.
8
Association between asthma and IgG levels specific for rhinovirus and respiratory syncytial virus antigens in children and adults.儿童和成人中哮喘与针对鼻病毒和呼吸道合胞病毒抗原的IgG水平之间的关联。
J Allergy Clin Immunol Glob. 2024 Sep 17;4(1):100342. doi: 10.1016/j.jacig.2024.100342. eCollection 2025 Feb.
9
The production, function, and clinical applications of IL-33 in type 2 inflammation-related respiratory diseases.IL-33 在 2 型炎症相关呼吸疾病中的产生、功能及临床应用。
Front Immunol. 2024 Sep 5;15:1436437. doi: 10.3389/fimmu.2024.1436437. eCollection 2024.
10
Disease Severity and Cytokine Expression in the Rhinovirus-Induced First Wheezing Episode.病毒诱导的首次喘息发作的疾病严重程度和细胞因子表达。
Viruses. 2024 Jun 7;16(6):924. doi: 10.3390/v16060924.

本文引用的文献

1
IL-17E (IL-25) and IL-17RB promote respiratory syncytial virus-induced pulmonary disease.白细胞介素-17E(白细胞介素-25)和白细胞介素-17受体B促进呼吸道合胞病毒诱导的肺部疾病。
J Leukoc Biol. 2014 May;95(5):809-815. doi: 10.1189/jlb.0913482. Epub 2014 Jan 9.
2
IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction.IL-33 比 IL-25 更能引发产生 IL-13 的 nuocytes(2 型先天淋巴样细胞)和气道收缩。
J Allergy Clin Immunol. 2013 Oct;132(4):933-41. doi: 10.1016/j.jaci.2013.05.012. Epub 2013 Jun 27.
3
Dupilumab in persistent asthma with elevated eosinophil levels.度普利尤单抗治疗嗜酸性粒细胞水平升高的持续性哮喘。
N Engl J Med. 2013 Jun 27;368(26):2455-66. doi: 10.1056/NEJMoa1304048. Epub 2013 May 21.
4
TH2, allergy and group 2 innate lymphoid cells.TH2 细胞、过敏和 2 类固有淋巴细胞。
Nat Immunol. 2013 Jun;14(6):536-42. doi: 10.1038/ni.2617.
5
Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types.人鼻病毒 A、B 和 C 种的分类建议,归入基因型指定的类型。
J Gen Virol. 2013 Aug;94(Pt 8):1791-1806. doi: 10.1099/vir.0.053686-0. Epub 2013 May 15.
6
Toll-like receptor 7 gene deficiency and early-life Pneumovirus infection interact to predispose toward the development of asthma-like pathology in mice.Toll 样受体 7 基因缺陷和生命早期呼吸道合胞病毒感染相互作用,使小鼠易于发展为哮喘样病理。
J Allergy Clin Immunol. 2013 May;131(5):1331-9.e10. doi: 10.1016/j.jaci.2013.02.041. Epub 2013 Apr 2.
7
Innate lymphoid cells--a proposal for uniform nomenclature.先天淋巴细胞——统一命名的建议。
Nat Rev Immunol. 2013 Feb;13(2):145-9. doi: 10.1038/nri3365.
8
The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity.E3 泛素连接酶中线 1 通过抑制蛋白磷酸酶 2A 活性促进过敏原和鼻病毒引起的哮喘。
Nat Med. 2013 Feb;19(2):232-7. doi: 10.1038/nm.3049. Epub 2013 Jan 20.
9
Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus.定义 NF-κB p65 和 I 型干扰素在鼻病毒先天免疫中的关键作用。
EMBO Mol Med. 2012 Dec;4(12):1244-60. doi: 10.1002/emmm.201201650. Epub 2012 Nov 14.
10
Human rhinovirus species and season of infection determine illness severity.人类鼻病毒的种类和感染季节决定疾病的严重程度。
Am J Respir Crit Care Med. 2012 Nov 1;186(9):886-91. doi: 10.1164/rccm.201202-0330OC. Epub 2012 Aug 23.